LifeStance (LFST) insider purchases 67,670 shares at $4.30–$4.54

Rhea-AI Filing Summary

Kenneth A. Burdick, a director of LifeStance Health Group, Inc. (LFST), reported multiple open-market purchases of common stock on August 8 and August 11, 2025. The filings show acquisitions totaling 67,670 shares at prices between $4.30 and $4.54. After these transactions his reported direct beneficial ownership rose to 3,436,571 shares, and he also holds 46,511 shares indirectly through Burdick Family LLC.

Positive

• Insider purchases totaling 67,670 shares were reported, indicating increased insider ownership.
• Direct beneficial ownership increased to 3,436,571 shares, with indirect holdings of 46,511 shares via Burdick Family LLC.

Negative

• None.

Insights

Securities Analyst

TL;DR: Director made repeated purchases totaling 67,670 shares at low single-digit dollar prices; direct holdings rose to ~3.44M.

The Form 4 shows Kenneth Burdick executed multiple purchases on August 8 and August 11, 2025, adding 67,670 common shares at prices ranging from $4.30 to $4.54. The filing reports direct beneficial ownership of 3,436,571 shares and an indirect holding of 46,511 shares via Burdick Family LLC. These entries are routine insider buy disclosures and, based solely on the reported figures, reflect increased insider share ownership without additional context on materiality or intent.

Corporate Governance Expert

TL;DR: Multiple insider purchases reported; disclosure appears complete with direct and indirect holdings identified.

The filing identifies the reporting person as a director and itemizes each purchase by date, share count, and price. It also distinguishes direct versus indirect ownership and names the indirect vehicle (Burdick Family LLC). From a governance and compliance perspective, the Form 4 provides the expected details required under Section 16, showing transparency on the insider's holdings after the transactions.

Insider Trade Summary

Net Buyer: 114,181 shares ($498,294)

Net Buy 5 txns

Insider Burdick Kenneth A

Role Director

Bought 114,181 shs ($498K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,340	$4.35	$6K
Purchase	Common Stock	18,660	$4.54	$85K
Purchase	Common Stock	45,870	$4.36	$200K
Purchase	Common Stock	1,800	$4.31	$8K
Purchase	Common Stock	46,511	$4.30	$200K

Holdings After Transaction: Common Stock — 3,417,991 shares (Direct); Common Stock — 46,511 shares (Indirect, By Burdick Family LLC)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burdick Kenneth A

(Last) (First) (Middle)

C/O LIFESTANCE HEALTH GROUP, INC.

4800 N. SCOTTSDALE ROAD, SUITE 2500

(Street)

SCOTTSDALE AZ 85251

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LifeStance Health Group, Inc. [ LFST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/08/2025		P		45,870	A	$4.36	3,414,771	D
Common Stock	08/08/2025		P		1,800	A	$4.31	3,416,571	D
Common Stock	08/11/2025		P		1,340	A	$4.35	3,417,991	D
Common Stock	08/11/2025		P		18,660	A	$4.54	3,436,571	D
Common Stock	08/08/2025		P		46,511	A	$4.3	46,511	I	By Burdick Family LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	By: /s/ Ryan Pardo, Attorney-in-Fact	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did LifeStance (LFST) report on this Form 4?

The Form 4 reports that director Kenneth A. Burdick purchased a total of 67,670 common shares on August 8 and August 11, 2025 at prices ranging from $4.30 to $4.54.

How many shares does Kenneth Burdick directly and indirectly own after these transactions?

Following the reported transactions, he reported 3,436,571 shares directly and 46,511 shares indirectly held through Burdick Family LLC.

Were the transactions open-market purchases or derivative transactions?

The filing shows non-derivative common stock purchases (transaction code P), indicating acquisitions of common shares rather than derivative instruments.

Does the Form 4 show who signed the filing?

The Form 4 includes a signature line indicating the filing was submitted by an attorney-in-fact, as shown in the document, but it does not change the reported transaction details.